Mathiot, L.; Herbreteau, G.; Robin, S.; Fenat, C.; Bennouna, J.; Blanquart, C.; Denis, M.; Pons-Tostivint, E.
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature. Curr. Oncol. 2022, 29, 3748-3758.
https://doi.org/10.3390/curroncol29050300
AMA Style
Mathiot L, Herbreteau G, Robin S, Fenat C, Bennouna J, Blanquart C, Denis M, Pons-Tostivint E.
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature. Current Oncology. 2022; 29(5):3748-3758.
https://doi.org/10.3390/curroncol29050300
Chicago/Turabian Style
Mathiot, Laurent, Guillaume Herbreteau, Siméon Robin, Charlotte Fenat, Jaafar Bennouna, Christophe Blanquart, Marc Denis, and Elvire Pons-Tostivint.
2022. "HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature" Current Oncology 29, no. 5: 3748-3758.
https://doi.org/10.3390/curroncol29050300
APA Style
Mathiot, L., Herbreteau, G., Robin, S., Fenat, C., Bennouna, J., Blanquart, C., Denis, M., & Pons-Tostivint, E.
(2022). HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature. Current Oncology, 29(5), 3748-3758.
https://doi.org/10.3390/curroncol29050300